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The establishment of tolerance is a prerequisite to obtain successful trans-
plantation and to achieve a stable chimerism. Despite the numerous studies
undertaken in animal bone marrow chimeras (1-3), the mechanisms underlying
the induction and maintenance of transplantation tolerance are still unclear.
The elucidation of these mechanisms is essential not only to provide a way to
induce tolerance to allografts, but also to gain understanding of the discrimi-
nation between self and non-self.
Patients suffering from severe combined immunodeficiency (SCID)' are nat-
urally devoid of T cells. Because of the absence of specific T cell-mediated
immune responses, transplants of allogeneic immature lymphoid cells are rela-
tively easily accepted. However, the development of graft-versus-host disease
(GVHD) by the newly implanted donor immune system exposes every host tissue
to immunologic attack.
Recently we described a SCID patient in whom HLA-incompatible fetal liver
and thymus transplantation (FLTT) has been successfully used (4, 5). The HLA
typing performed over the years revealed a stable engraftment of T cells from
the transplant, whereas the B cells and monocytes remained of host origin (6).
The follow up is 10 yr now.
Despite the complete HLA mismatch between donor-derived T lymphocytes
and recipient cells, no signs of acute or chronic GVHD have been observed.
Furthermore, donor-derived T lymphocytes appeared to be able to cooperate
with host cells since normal in vivo and in vitro antibody responses against thy-
mus-dependent antigens such as tetanus toxoid (TT) were obtained (6).
These observations suggested that the fetal lymphocytes, progressively differ-
entiating in an allogeneic environment, acquired tolerance towards the host
HLA determinants and became able to recognize them as restriction elements
in response to foreign antigens. To better define the mechanisms underlying this
process of self-education and acquisition of tolerance, we established a series of
T cell clones from the PBL of the patient.
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In the present paper, we describe eight selected T cell clones that reacted
specifically with the class I or class II HLA antigens of the recipient cells in
vitro. Both proliferative and cytotoxic responses were observed, indicating that
the establishment of transplantation tolerance observed in this stable human chi-
mera is not due to the elimination of host-reactive T cells from the repertoire.
In addition, to our knowledge this is the first demonstration of autocytotoxic
cells directed against class I HLA antigens in human.
Materials and Methods
Patient.
￿
The infant S.P. had a family history of SCID and was brought up in a strict
isolation from birth. At the age of 1 and 5 mo, he received FLTT from two different
HLA incompatible donors, 13 and 10 wk old (gestational age), respectively. The clinical
course of the patient before and after transplantations has been reported in detail pre-
viously (4) .
The patient is 11 yr old now, he shows a normal evolutive growth, and is in apparent
good health. The clinical course of occasional minor upper respiratory infections occur-
ring over the years had been mild and not different from that observed in normal chil-
dren. Despite a normal total lymphocyte count, he has a persistent inverted CD4+/CD8+
ratio ranging from 0.56 to 0.78. He has a regular immunization history with TT and
received the last booster injection 4 yr ago.
Establishment and Culture of T Cell Clones.
￿
Autoreactive T cell clones were obtained
during the process of generating TT-specific T cell clones from patient's PBL. 106 PBL
were suspended in 1 ml Yssel's medium (7) supplemented with 1% human AB' serum
(heat inactivated, 30 min at 56°C) and were stimulated with TT (Calbiochem-Behring
Corp, La Jolla, CA) at a concentration of 25 ug/ml .
After incubation at 37°C in 5% C02 for 5 d, these TT-activated cells were resuspended
in medium containing 20 IU rIL-2 per milliliter (kindly provided by Dr. R. Kastelein,
DNAX Research Institute, Palo Alto, CA). 10 d after the onset of the culture the cell
sample was restimulated with a feeder cell mixture consisting of 106 irradiated (4,000
rad) allogeneic lymphocytes per milliliter, 105 irradiated (5,000 rad) cells per milliliter of
the patient's EBV-transformed B cell line (SPS), and 0 .1 Ag per milliliter purified PHA
(Wellcome Diagnostics, Beckenham, Kent, UK) .
Another 12 d later, the cells were cloned by limiting dilution at a concentration of one
cell per three wells in a Titertek 96-well round-bottomed plate (Flow Laboratories,
Irvine, Scotland) in the presence of the feeder cell mixture described above and TT.
After 14 d, proliferating T cell cultures were transferred into 24-well tissue culture plates
(Linbro, Flow Laboratories) and restimulated with the feeder cell mixture. The clones
were further expanded in medium containing IL-2. 10 d after the last stimulation the
clones were screened for specificity and functional activity as described below.
Cell Lines.
￿
The EBV-transformed cell lines of the patient (SPS), his father (UD93),
and his mother (UD94) were originated from infection of fresh PBL with EBV obtained
from the marmoset lymphoblastoid cell line B 95-8. All cell lines were cultured in Yssel's
medium supplemented with 1 % human AB' serum.
HLA Typing.
￿
HLA typing was carried out on the T cell clones and EBV-transformed
B cell lines using a cytotoxicity assay previously described (8) .
Proliferation Assays.
￿
2 X 104 T cells that had been rested for 10-12 d after addition
of the feeder mixture were mixed with 2 X 104 irradiated (5,000 rad) stimulator cells in
the presence or absence of antigens in 200 11 Yssel's medium. After 3 d of incubation,
1 uCi (37 kBq)[;H]TdR (New England Nuclear, Dreieich, Federal Republic of Germany)
was added to each well . 4 h later, the cells were harvested onto
￿
lass fiber strips using a
semi-automated cell harvester and the amount of incorporated [ H]TdR was assessed by
liquid scintillation counting. The results are expressed as the mean of triplicate cultures
± the standard deviation. The effect of mAbs on the proliferative capacity was deter-
mined by adding varied amounts of mAb to the responder cell-stimulator cell mixtures
at the onset of the cultures.RONCAROLO ET AL.
￿
1525
Cytotoxicity Assays.
￿
Cytotoxic activity was determined using a 5'Cr-release assay. Effec-
tor cells were mixed with either 103 (EBV cell lines) or 104 (PBL) of - 'Cr-labeled target
cells in 200 A1 Iscove medium (Gibco, Glasgow, Scotland) with 0.25% BSA in U-shaped
wells of a microtiter plate, spun down at 50 g, and incubated for 4 h at 37'C in a hum-
idified atmosphere of 5% COI. The supernatants were harvested using a Skatron super-
natant collection system (Skatron, Lier, Norway) and were counted in a gamma counter.
Each effector-to-target cell interaction was measured in triplicate and the data are pre-
sented as percent specific "Cr release, which is determined as follows: 5'Cr release =
100 X [(experimental release - SR)/(MR - SR)]. The maximum release (MR) was
determined after incubation of the cells in I% Triton X-100 and the spontaneous release
(SR) by measuring the release of target cells in medium only. To determine the capacity
of mAbs to affect the Cytotoxic reaction, target cells were preincubated with mAb for 15
min at room temperature. The cells were then mixed with effector cells and the
51Cr-
release assay was carried out as described above.
Monoclonal Antibodies. The anti-CD2 mAb used in this study was CLB-Tl1 (kindly
provided by Dr. R. Van Lier, Central Laboratory of the Netherlands Red Cross Blood
Transfusion Service). The anti-CD4 mAb RIV6 was a kind gift of Dr. Kreeftenberg
(R.I.V. Bilthoven, The Netherlands). The anti-CD8 mAb SPV-T8 and the anti-CD3 mAb
SPV-T3b have been described before (9). The mAb W6/32, which detects a common
determinant on all class I HLA molecules, was obtained from Sera Lab (Crawley Down,
U.K.). The antibody SPV-L3 reacts with a monomorphic determinant on HLA-DQ mol-
ecules (9). The mAb Q5/13 was a kind gift from Dr. S. Ferrone (Medical College, Val-
halla, NY) and detects a determinant common to HLA-DR and HLA-DP molecules (10).
Fluorescence Analysis.
￿
105 cells were added per well of a V-bottomed microtiter plate
and washed once with PBS containing 0.02 mM NaN3 and 1% BSA. The cells were then
incubated with mAbs for 30 min at 4°C. After two washes in PBS/azide/BSA, the cells
were incubated with a 1 :40 dilution of FITC-labeled F (ab')I fragments of a goat anti-
mouse antibody (Bioart, Meudon, France) and incubated for 30 min at 4°C. After three
washes, the cells were transferred to FAGS tubes (Becton Dickinson & Co., Oxnard, CA)
and analyzed on a FAGS 440 (Becton Dickinson & Co.).
Results
HLA Typing.
￿
The HLA typing of parental PBL and patient's PBL before
transplantation is shown in Table I. HLA typing of the patient's PBL, carried
out by conventional Cytotoxicity assay during the follow up after transplant,
revealed the progressive engraftment of cells from the second donor (HLA-
A1,2 ; C7 ; 138,18 ; DR3,9), while the cells from the first donor (HLA-A2,11 ; C4;
1362,27; DR1,8), present at low numbers at the beginning, progressively became
undetectable (4, 6).
Furthermore, the HLA typing, performed 7 yr after transplantation on sep-
arated T and B cell populations and monocytes (Table I), indicated that all the
B lymphocytes and monocytes remained of host origin, whereas the T lympho-
cytes were donor derived (6).
HLA typing of the T cell clones and the EBV-transformed B cell line obtained
from the patient's PBL confirmed this complete split chimerism. All the auto-
reactive T cell clones have the phenotype of the second donor: HLA-A1,2; C7;
138,18; DR3,9, whereas the EBV-transformed B cell line SPS has the recipient
phenotype: HLA-A33,3; C6,2 ; 1314,47; DR4,5. It has to be mentioned that the
recent HLA typing on T cell clones differs for DR locus from initial typing car-
ried out 6 yr ago on patient's PBL (HLA-DR 3,9 instead of HLA-DR1,7) .
Screening and Characterization of Autoreactive T Cell Clones.
￿
In the course of
the screening performed as described in Materials and Methods, 15 of 50 clones1526
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TABLE I
HLA Typing of the FLTT Subject and His Parents
* HLA genotypes of the family
HLA phenotype of patient 7 y after the transplant. HLA typing was carried out
on enriched cell populations.
were obtained that proliferated in response to SPS (Table II). The majority of
these clones were also cytotoxic for SPS. The proliferative response and the
cytotoxic activity were not enhanced when TT was added to the culture (not
shown). Phenotyping of these autoreactive clones showed that all the 15 clones
were CD2+, CD3+, 6 were CD4+, and 9 were CD8+ (Table II).
The clones SP-A3, SP-A10, SP-1323, SP-1333, SP-C5, SP-C6, SP-1347, and SP-
D68, which displayed the highest proliferative and cytotoxic activity against SPS,
were selected for further characterization.
To determine whether the responses of these clones to SPS (recipient cells)
were specific, we examined the capacity of allogeneic EBV-transformed B cell
lines to induce proliferation. In addition, the cytotoxic activity of the clones
against allogeneic target cells was tested. In Table III it is shown that the T cell
clones were specifically reacting with stimulator/target cells sharing HLA-A3
(NOB) or HLA-DR4 (JY) antigens with SPS, whereas they did not react with the
cell lines HSY, IAD and QBL which share no HLA determinants with SPS.
Specificity Study.
￿
The nature of the self-determinants recognized by the auto-
reactive T cell clones of donor origin was examined by blocking studies with
niAbs directed against class I and II HLA antigens.
The proliferation of the three CD4+ clones (SP-A3, SP-1123, SP-1133) in
response to SPS was blocked by the anti-HLA-DR, DP mAb Q5/13. In contrast,
mAbs against HLA-DQ (SPV-L3) and HLA-A, B, C (W6/32) were ineffective
(Table IV). The inhibition by Q5/13 was specific since this mAb was unable to
affect the proliferative activity of the CD8+ class I MHC-specific T cell clone
SP-C5 (Table IV). Comparable results were obtained for the T cell clones SP-
A3 and SP-1123 in the cytotoxicity assay (Table V), since the anti-HLA-DR mAb
blocked their cytotoxic reactivity against SPS whereas the mAbs against HLA-
DQ and class I HLA antigens were ineffective. These findings indicate that the
Subject HLA locus
A
HLA locus
C
HLA locus
B
HLA locus
DR
Father*
a 1 W4 17 7
b W33 W6 14 4
Mother*
c 3 W2 W47 5
d W26 W4 12 1
Patient*
b W33 W6 14 4
c 3 W2 W47 5
Patient-
T cells donor 1-2 W7 8-18 3-9
B cells host W33-3 W6 14-W47 4-5
Monocytes host W33-3 14-W47 4-5TABLE II
Proliferative and Cytotoxic Responses ofAutoreactive TCell Clones
against the Host-derived EBV-transformedB Cell Line (SPS)
RONCAROLO ET AL .
* All the clones were CD2+ and CD3 + .
: Responder/stimulator cell ratio 1 :1 . In all cases the SD was < 10% of
the totalcpm andthe proliferation ofT cells in the absence of stimulator
cells was < 0.5 X 10-" cpm
4 Effector/target cell ratio 10 :1 .
TABLE III
Proliferative Response and Cytotoxic Activity ofAutoreactive TCell Clones against Allogeneic
EBV-transformed B Cell Lines
Stimulator/target cells
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* HLA phenotype of the allogeneic EBV-transformed cell lines.
Values represent the mean [sH]TdR incorporation at a responder/stimulator cell ratio of 1 :1 .
$ Values represent the mean percent of 5 ' Cr release at an E/'T cell ratio of 10:1 .
Underlining indicates positive reactivity .
T cell
clones
NOB
[A3 B7 DR2
DQ2]*
cpm: Lysis§
JY
[A2 117 DR4,6]
cpm Lysis
QBL
[A26 B18
DQ3]
cpm
DR3
Lysis
HSY
[A1,19 118,13
DR3,71
cpm Lysis
IAD
[A1,21313,17
DR7,13 DQl]
cpm Lysis
X10-3 % X10-3 R'o X10-3 4'o X10-3 % X10-3 %
SP-A3 0.1 0 70.8 18.5 0.1 8.1 0.02 3.3 0.05 2.4
SP-A10 1 .3 2.3 0.8 0 1 .3 10 .1 0.4 4.1 0 3.4
SP-1123 1 .8 8.3 75.3 67.7 0 5.8 0.02 0 0 6.5
SP-1333 3.8 0 13.0 1 .7 0.3 5.5 1.2 6.4 0.6 3.2
SP-C5 11 .0 11 67.8 0.07 2 .7 0.1 1 .8 0.02 4 0.3 6.2
SP-C6 1 .0 0 0 .2 10 .3 0.8 4.2 2 .2 6 0.2 7.5
SP-1147 0.5 10 0 8.2 0 1 .9 0.4 9.1 .08 4.3
SP-1168 69 .1 60.8 0 .3 5 0.7 1 .5 0.1 0 2.1 8
T cell
clones Phenotype*
Proliferation :
(['H]TdR
incorporation)
Cytotoxicity¢
(5'Cr
release)
cpm X 10-3 %
SP-A3 CD4+ 80 .3 25
SP-A8 CD8+ 5.3 27
SP-A10 CD8+ 12 .3 37
SP-1118 CD4+ 8.5 32
SP-1323 CD4+ 83.2 35
SP-1324 CD4+ 15.0 0
SP-1330 CD8+ 14.4 28
SP-1333 CD4+ 78.0 0
SP-1335 CD8+ 13.8 0
SP-1337 CD4+ 12.7 0
SP-C5 CD8+ 8.2 63
SP-C6 CD8+ 7.9 50
SP-C12 CD8+ 5.0 40
SP-1147 CD8+ 8.3 51
SP-1368 CD8+ 12.9 601528
TABLE IV
Effect of Anti-HLA mAbs on the Proliferative Responses of TCell Clones against SPS
Responder/stimulator cell ratiowas 1 :1
* mAbs were used at a final dilution of 1:200 of ascites fluid
tValues represent the mean [3H]TdR incorporation ± SD.
CD4+ autoreactive clones derived from the donor T cells (HLA-DR 3,9) rec-
ognize HLA-DR 4 or HLA-DR 5 determinants on the recipient cells.
The cytotoxic activity of the five CD8+ clones (SP-A10, SP-C5, SP-C6, SP-
D47, SP-1368) against SPS was blocked by anti-HLA-A, B, C mAb (W6/32), but
not by anti-HLA-DQ (SPV-L3) and HLA-DR (Q5/13) mAbs (Table V). As
expected, W6/32 did not inhibit the cytotoxic activity of T cell clones SP-A3
and SP-1323, which are class II MHC specific (Table V). Moreover the prolifer-
ative response of the CD8+ clone SP-C5 to SPS was inhibited by W6/32 (Table
IV). These data demonstrate that the CD8+ T cell clones (HLA-A1,2; C7; 138,18)
recognize HLA class I determinants (HLA-A33,3; C6,2; 1314,47) of the recipient
that resulted in cytotoxic as well as proliferative responses.
Family Study.
￿
To get more information on the fine specificity of these auto-
reactive T cell clones, we tested the proliferative responses of the CD4+ clones
and the cytotoxic activity of the CD8+ clones against the parental EBV-trans-
formed B cell lines. The response against patient's and parental fresh PBL and
PHA blasts was determined in parallel, to exclude a reactivity either to foreign
antigens introduced by the in vitro culture or to EBV antigens .
TABLE V
Effect ofAnti-HLA mAbs on the Cytotoxic Activity of 7' Cell Clones against SPS
AUTOREACTIVE CELL CLONES IN A HUMAN CHIMERA
* E/Tcell ratioof 10:1 .
t mAbs were used at a final dilution of 1 :200 of ascites fluid.
mAb added-
Percent inhibition of cytotoxicity with effector
SP-A10 SP-C5 SP-C6 SP-1347 SP-1368
T cell clones:*
SP-A3 SP-1323
W6/32 [anti HLA-A, B, 100 91 100 77 98 0 0
C]
SPV-L3 [anti HLA-DQ] 0 0 0 0 0 0 0
Q5/13 [anti HLA-DR,DP] 0 0 0 0 0 100 87
Percentlysis in the 36 44 50 53 55 14 39
absence of mAbs
mAb added*
Percent inhibition
SP-A3
of proliferation
SP-1323
with responder
SP-1333
Tcell clones:
SP-C5
W6/32 [anti HLA-A, B, C] 6 11 0 92
SPV-L3 [anti HLA-DQ] 3 0 0 0
Q5/13 [anti HLA-DR, DP] 90 100 65 0
Proliferative response in 28.5±2 .5 44.2±3.3 78 .0±3.4 4.0±0.5
the absence of mAbs
(cpm X 10-'),TABLE VI
Family Study of (CD4+, CD8-)Autoreactive Proliferative TCell Clones
Stimulator cells*
EBVcell lines
"Autologous" (SPS)
Mother (UD94)
Father (UD93)
PBL
Mother
Father
* Responder/stimulator cell ratio was 1 :1 . In all cases, spontaneous ['H]TdR incorpo-
ration of T cells in the absence of stimulator cells was < 0.7 X 10-s cpm.
I Results are ± SD.
In Table VI it is shown that the CD4+ class II HLA-specific T cell clones SP-
A3 and SP-1123 both proliferated in response to the patient's EBV cell line SPS
(HLA-DR 4,5), but not in response to his PHA-stimulated T lymphoblasts
(HLA-DR 3,9) (not shown). Furthermore, they proliferated in the presence of
the father's EBV cell line UD93 and fresh PBL, sharing the HLA-DR4 antigen
with the patient. No responses to the mother's EBV cell line UD94 and fresh
PBL that share the HLA-DR5 antigen with the patient were observed. Clone
SP-1333 proliferated in response to SPS and UD93 sharing HLA-DR4. These
results combined with the proliferation induced by JY (Table III) and the block-
ing experiments with the mAbs (Table IV) suggest that all three CD4 + clones
recognize an epitope present on HLA-DR4 .
In Table VII it is shown that the CD8+ clones were cytotoxic for SPS and
TABLE VII
Family Study of (CD4-, CD8+)Autoreactive Cytotoxic TCell Clones
* EST ratio was 10:1 .
RONCAROLO ET AL.
[sH]TdR incorporation with responderT cell clones:
SP-A3 SP-1123 SP-1133
CPm X 10-'"
28.6±3 .5 44.2±3.3 78.0±3.4
0.1
￿
0.6
￿
1.3
20.3±1 .5 40.8±5.9 63.7±2.3
0.7
￿
0.3
￿
ND
3.3 ± 1.1
￿
5.3 ± 0.4
￿
ND
Percent 5'Crrelease with effector T cell clones:
1529
Target cells*
SP-A10 SP-C5 SP-C6 SP-D47 SP-D68
EBV cell lines
"Autologous" (SPS) 37 30 40 41 34
Mother (UD94) 40 48 5 4 47
Father (UD93) 7 4 68 63 0
PHABlasts
Patient ND 0 0 3 0
Mother ND 26 0 9 42
Father ND 0 34 28 0
PBL
Patient ND 19 20 18 23
Mother 86 74 0 0 17
Father 0 0 16 21 01530
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fresh PBL of the patient that contain B cells and monocytes of the recipient. In
contrast, the PHA blasts were not lysed, since they are entirely of donor origin
and consequently have the same HLA determinants as the T cell clones. Fur-
thermore, the clones SP-A10, SP-C5, and SP-D68 display cytotoxic activity
against the mother's EBV cell line UD94, PBL, and PHA blasts (Table VII),
suggesting that they interact with either the class I HLA antigens A3, C2, or
B47 antigens shared with the mother. Since we demonstrated that clones SP-C5
and SP-D68 are also cytotoxic towards the EBV cell line NOB (Table III), which
expresses the HLA-A3 determinant, we conclude that these clones are specific
for HLA-A3. Clones SP-C6 and SP-D47 were cytotoxic against the EBV cell line
UD93, PBL, and PHA blasts of the father, suggesting that they are specific for
either the class I HLA antigens A33, C6, or B14 antigen shared with the father.
Discussion
We studied a patient suffering from SLID who has been successfully trans-
planted with two subsequent HLA-mismatched FLTT >I 0 yr ago. This trans-
plantation resulted in the progressive differentiation of donor lymphoid cells in
the HLA-incompatible host environment (4, 5).
In this child we observed the stable engraftment of only T cells from the sec-
ond transplant, while the fetal cells from the first donor, present at low concen-
trations shortly after transplantation, became progressively undetectable in
peripheral blood. The B cells and monocytes remained exclusively of host origin
(6).
Despite this situation of stable split chimerism with a complete HLA mismatch
between donor-derived T lymphocytes and recipient cells, no signs of acute or
chronic GVHD were observed and full immunological reconstitution has been
achieved. Recently, we demonstrated that the T cells of donor origin were able
to cooperate with recipient non-T cells across the allogeneic barrier (6, Roncar-
olo, M. G., et al., manuscript submitted for publication).
Therefore, this patient provides an unique model to gain insight in the under-
standing of education or selection of self recognition resulting in acquisition of
tolerance. For this reason, a study of clonal level of patient's PBL has been
performed.
A series of T cell clones specifically reacting against recipient cells were
obtained from the PBL of the patient. All these autoreactive clones had prolif-
erative activity and 11 of 15 were also cytotoxic.
The specfiy of these T cell clones was documented by their reactivity with
the patient's EBV-transformed B cell line, with the parental haploidentical EBV
cell lines and with EBV cell lines from unrelated subjects sharing the relevant
HLA antigens. No reactivity with EBV cell lines bearing nonshared HLA anti-
gens was observed. The clones displayed cytotoxic activity against the parents'
PHA blasts, demonstrating that they were not directed against viral antigens
present on the EBV transformed B cell lines. Furthermore, the observation that
cytotoxic/proliferative activity was detected also against fresh PBL exclude the
possibility that the T cell clones recognize foreign antigens introduced by in
vitro culture.RONCAROLO ET AL.
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Most strikingly in this study we demonstrate that all the CD8+ autoreactive T
cell clones recognized the class I HLA determinants of the recipient. Autoreac-
tive T cells and T cell clones have been described in patients suffering from
autoimmune diseases or in situations where autoaggressive processes occur (11-
13). In addition, autoreactive T cells and T cell clones have been generated in
vitro from autologous mixed lymphocyte cultures carried out with lymphocytes
of healthy donors (14), normal T cells activated by autologous antigen specific
T cell clones (15), and from T cell cultures activated by soluble antigens (16,
17). However, in contrast to the clones obtained in our study, all autoreactive
clones isolated either from normal donors or from patients suffering from
autoimmune diseases described thus far, were either specifically directed against
class 11 HLA determinants or their activities were class 11 HLA restricted (11-
17).
Class 11 HLA determinants are only expressed at low levels on a limited num-
ber of cell types. Therefore, it has been proposed that even if class 11 HLA
specific autoreactive T lymphocytes do exist in vivo, they would only affect the
limited number of cell types bearing sufficient class II HLA antigens (14, 16).
In addition, such clones have been considered to represent a normal regulatory
mechanism involving class II HLA molecules (15-17).
From our patient we isolated autoreactive T cell clones recognizing class I
HLA antigens which are ubiquitous and highly expressed in the organism. Con-
sequently, if these autocytotoxic cells are operational in vivo they would con-
stantly attack every cell and tissue of the host.
Comparable T cell clones directed against either the class I or class 11 HLA
antigens of recipient or donor have been isolated in vivo from graft-infiltrating
lymphoid cells of transplanted patients in whom acute fatal GVHD or irrevers-
ible graft rejection occurred (18) . However, in the patient described here, these
class I HLA-specific autocytotoxic cells or their precursors could exist in vivo
>10 yr after the transplant without any apparent pathological manifestations .
Therefore, the possibility of a peripheral autoregulatory suppressor mechanism,
as has been described for some animal models (2, 19-22), could be put forward.
In particular, it could be that cells are present in vivo that are either able to
prevent the differentiation of autoreactive precursor cells or to inactivate the
autoagressive effector cells. Further investigations are in progress to determine
this suppressor mechanism. These studies are becoming more complicated now,
since we have observed that a proportion of TT-specific T cell clones, recently
isolated from patient's PBL after an in vivo booster with TT, expressed the HLA
phenotype of the first donor (Roncarolo, M. G., et al., manuscript submitted for
publication). This finding indicates that, in spite of the fact that T cells from the
first transplant were not detectable in PBL by conventional HLA typing, these
cells are circulating and can become functional. Thus we must envisage not only
an induction of tolerance of the T cells derived from the two transplants towards
the non-T cells of the patient, but also towards each other. Perhaps tolerance
between these two completely mismatched mature populations of transplanted
T cells involves veto cells that can be responsible for the mutual in vivo toleri-
zation (23, 24). In contrast, the T cells of donor origin reacting in vitro against
the HLA antigens of the recipient cells could not be inactivated in vivo through1532
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a veto mechanism since the recipient CTL that have to veto donor-anti-recipi-
ent CTL are completely absent.
It is still unclear whether the thymus repopulates and a normal thymic edu-
cation takes place in SCID children transplanted with FLT-f. Furthermore, it is
not known whether the transplanted fetal liver cells migrate and are educated
in the host thymus or that they are educated in the donor's fetal thymus that
may have developed at the site of infusion (25).
Studies performed in human and animal HLA incompatible bone marrow
transplantation models suggested that intrathymic cells imprint the self-recog-
nition pattern of engrafted HLA-incompatible T cells and thus self tolerance
(26, 27). Therefore, in our patient the induction of tolerance could have
occurred through a mechanism of clonal deletion in the host thymus (28). How-
ever, the isolation from peripheral blood of various T cell clones of donor origin
specific for the recipient HLA determinants excludes this possibility and dem-
onstrates that at least no complete elimination of host-reactive cells in the thy-
mus took place.
It is noteworthy that the patient has an inverted ratio of CD4+/CD8+ cells
and that a high spontaneous [3H]TdR incorporation by PBL was measured (4,
6). These observations suggest the presence of ongoing activation processes
involving CD8+ T cells. Whether this reflects the maintenance of an active
peripheral suppressor mechanism remains to be determined.
Summary
T cell clones of donor origin that specifically react with recipient cells were
obtained from a SCID patient successfully reconstituted by allogeneic fetal liver
and thymus transplantation performed 10 yr ago. The majority of these clones
displayed both cytotoxic and proliferative responses towards PBL and an EBV-
transformed B cell line derived from the patient. In addition, these T cell clones
had proliferative and cytotoxic responses towards the parental PBL, EBV cell
lines, and PHA blasts. Blocking studies with anti-class I and anti-class II HLA
mAbs indicated that the activity of the CD4+ T cell clones was specifically
directed against class II HLA antigens of the recipient. On the other hand, the
cytotoxic and proliferative responses of the CD8+ T cell clones were specific for
class I HLA antigens which are ubiquitously expressed on the recipient cells.
Thus, the establishment of transplantation tolerance observed in this stable
human chimera is not due to the elimination of host-reactive T cells from the
repertoire and suggests the presence of a peripheral autoregulatory suppressor
mechanism.
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